Cargando…
Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection
Intrahepatic cholangiocarcinoma (ICC) is a cancer type with high malignancy and a current lack of biomarkers to predict recurrence. In the present study, to identify potential biomarkers, five ICC datasets from the Gene Expression Omnibus database were analyzed to construct initial datasets by using...
Autores principales: | Chen, Fei-Yu, Zhou, Cheng, Zhang, Xiang-Yu, Zhou, Kai-Qian, Peng, Yuan-Fei, Yu, Lei, Fan, Jia, Zhou, Jian, Hu, Jie, Wang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480127/ https://www.ncbi.nlm.nih.gov/pubmed/32952640 http://dx.doi.org/10.3892/etm.2020.9178 |
Ejemplares similares
-
Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020) -
Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018) -
Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Qu, Wei-Feng, et al.
Publicado: (2020) -
Recurrence after Curative Resection for Intrahepatic Cholangiocarcinoma: How to Predict the Chance of Repeat Hepatectomy?
por: Langella, Serena, et al.
Publicado: (2021) -
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)